Versacloz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8057811 TASMAN PHARMA Stable clozapine suspension formulation
May, 2028

(4 years from now)

Versacloz is owned by Tasman Pharma.

Versacloz contains Clozapine.

Versacloz has a total of 1 drug patent out of which 0 drug patents have expired.

Versacloz was authorised for market use on 06 February, 2013.

Versacloz is available in suspension;oral dosage forms.

The generics of Versacloz are possible to be released after 01 May, 2028.

Drugs and Companies using CLOZAPINE ingredient

Market Authorisation Date: 06 February, 2013

Treatment: NA


More Information on Dosage

VERSACLOZ family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic